Company intelligence / Profile preview

Ciim Plus

Ownership: Private
Development stage: Other

Overview

Ciim Plus, d.o.o. has developed and clinically tested a device called PMA-zeolite for use in Crohn disease. The intervention involves the use of PMA-zeolite and cellulose as devices/interventions in at least one registered clinical trial[2]. No published results or efficacy data are available from these sources.

Therapeutic areas: Gastroenterology
Modalities: DeviceNon-pharmacological therapy (PMA-zeolite device)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Ciim Plus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciim Plus.

Explore the full profile